ST3GAL4 Antikörper
Kurzübersicht für ST3GAL4 Antikörper (ABIN2462999)
Target
Alle ST3GAL4 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Aufreinigung
- Antibody is purified by peptide affinity chromatography method.
-
Immunogen
- Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human ST3GAL4.
-
-
-
-
Applikationshinweise
- ST3GAL4 antibody can be used for detection of ST3GAL4 by ELISA at 1:312500. ST3GAL4 antibody can be used for detection of ST3GAL4 by western blot at 0.25 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50,000 - 100,000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 50 ?L of distilled water. Final antibody concentration is 1 mg/mL.
-
Konzentration
- 1 mg/mL
-
Buffer
- Antibody is lyophilized in PBS buffer with 2 % sucrose.
-
Handhabung
- As with any antibody avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- For short periods of storage (days) store at 4 °C. For longer periods of storage, store ST3GAL4 antibody at -20 °C.
-
-
- ST3GAL4 (ST3 beta-Galactoside alpha-2,3-Sialyltransferase 4 (ST3GAL4))
-
Andere Bezeichnung
- ST3GAL4
-
Hintergrund
- Synthesis of alpha-2,3-linked sialic acid to Gal (beta-1,3)GalNAc is mediated by at least 3 distinct beta-galactoside alpha-2,3-sialyltransferases (EC 2.4.99.4), including ST3GAL4. In contrast, only a single gene encodes the beta-galactoside alpha-2,6-sialyltransferase, ST6GAL1.
-
Molekulargewicht
- 37 kDa
-
Gen-ID
- 6484
-
NCBI Accession
- NP_006269
-
UniProt
- Q6IBE6
-
Pathways
- Glycosaminoglycan Metabolic Process
Target
-